List of molecules and drugs that target protein Q03181

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	Q03181_DB00132	DB00132	alpha-Linolenic acid	n/a	IC50(nM) = 16000.0	DTOSIQBPPRVQHS-PDBXOOCHSA-N	CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
2	Q03181_DB00159	DB00159	Icosapent	agonist	IC50(nM) = 4000.0	JAZBEHYOTPTENJ-JLNKQSITSA-N	CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
3	Q03181_DB00197	DB00197	Troglitazone	n/a		GXPHKUHSUJUWKP-UHFFFAOYSA-N	CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4	Q03181_DB00313	DB00313	Valproic acid	n/a		NIJJYAXOARWZEE-UHFFFAOYSA-N	CCCC(CCC)C(O)=O
5	Q03181_DB00374	DB00374	Treprostinil	agonist		PAJMKGZZBBTTOY-ZFORQUDYSA-N	[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
6	Q03181_DB00412	DB00412	Rosiglitazone	n/a	EC50(nM) = 5248.0	YASAKCUCGLMORW-UHFFFAOYSA-N	CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
7	Q03181_DB00605	DB00605	Sulindac	negative modulator		MLKXDPUZXIRXEP-MFOYZWKCSA-N	CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
8	Q03181_DB01393	DB01393	Bezafibrate	agonist	EC50(nM) = 18900.0	IIBYAHWJQTYFKB-UHFFFAOYSA-N	CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
9	Q03181_DB02746	DB02746	Phthalic Acid	n/a		XNGIFLGASWRNHJ-UHFFFAOYSA-N	OC(=O)C1=CC=CC=C1C(O)=O
10	Q03181_DB03338	DB03338	Heptyl glucoside	n/a		NIDYWHLDTIVRJT-UJPOAAIJSA-N	CCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
11	Q03181_DB04224	DB04224	Oleic Acid	n/a		ZQPPMHVWECSIRJ-MDZDMXLPSA-N	CCCCCCCC\C=C\CCCCCCCC(O)=O
12	Q03181_DB04801	DB04801	cis-Vaccenic acid	n/a		UWHZIFQPPBDJPM-FPLPWBNLSA-N	CCCCCC\C=C/CCCCCCCCCC(O)=O
13	Q03181_DB05187	DB05187	Elafibranor	n/a		AFLFKFHDSCQHOL-IZZDOVSWSA-N	CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1
14	Q03181_DB05188	DB05188	KD3010	n/a		SUTQDFLDQUPTKX-QVLMFNNZSA-N	CC1=CC=C(C=C1)S(O)(=O)=O.[H]C1(CC2=C(C1)C(=CC=C2)S(=O)(=O)N1[C@@]([H])(C)CN(C[C@@]1([H])C)C1=CC=C(OC(F)(F)F)C=C1)C(O)=O
15	Q03181_DB05416	DB05416	Cardarine	agonist	Ki(nM) = 0.048 IC50(nM) = 1.0 EC50(nM) = 0.18	YDBLKRPLXZNVNB-UHFFFAOYSA-N	CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F
16	Q03181_DB07070	DB07070	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	n/a	EC50(nM) = 12.0	BDLLIPYDNFENMY-ZDUSSCGKSA-N	[H][C@](CC)(CC1=CC(CNC(=O)C2=C(F)C=C(C=C2)C(F)(F)F)=C(OC)C=C1)C(O)=O
17	Q03181_DB07691	DB07691	2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid	n/a	IC50(nM) = 126.0 EC50(nM) = 1259.0	GYILVHHTCYNIOS-UHFFFAOYSA-N	OC(=O)C1=C(NC(=O)C2=CC=CC(=C2)S(=O)(=O)N2CCC3=CC=CC=C3C2)C=CC=C1
18	Q03181_DB07724	DB07724	Indeglitazar	n/a		YMPALHOKRBVHOJ-UHFFFAOYSA-N	COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
19	Q03181_DB08078	DB08078	{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid	n/a	IC50(nM) = 13.0 Kd(nM) = 76.0 EC50(nM) = 6.0 koff(s-1) = 0.43	HBBVCKCCQCQCTJ-UHFFFAOYSA-N	CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(C(C)=O)=C1O
20	Q03181_DB09006	DB09006	Clinofibrate	n/a		BMOVQUBVGICXQN-UHFFFAOYSA-N	CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O
21	Q03181_DB09462	DB09462	Glycerin	agonist		PEDCQBHIVMGVHV-UHFFFAOYSA-N	OCC(O)CO
22	Q03181_DB13873	DB13873	Fenofibric acid	unknown		MQOBSOSZFYZQOK-UHFFFAOYSA-N	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O